Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linsitinib in Relapsed or Refractory Ewing Sarcoma
NCT02546544Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Mar 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of linsitinib in Ewing sarcoma, sponsored by University of Oxford. Started Mar 2014; status: completed.
02
Drugs
linsitinib
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on NCT02546544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02546544.